HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Antero Kesäniemi Selected Research

Dyslipidemias (Dyslipidemia)

4/2009Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: the GEMS Study.
4/2008Genetic and phenotypic architecture of metabolic syndrome-associated components in dyslipidemic and normolipidemic subjects: the GEMS Study.
6/2007Serum insulin and inflammatory markers in overweight individuals with and without dyslipidemia.
3/2006Association between angiotensin-converting enzyme insertion/deletion polymorphism and treatment response in type 2 diabetic patients.
10/2005Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemia.
1/2005Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Antero Kesäniemi Research Topics

Disease

30Atherosclerosis
01/2021 - 03/2002
16Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2021 - 01/2005
14Aortic Valve Stenosis (Aortic Stenosis)
01/2022 - 09/2008
13Obesity
12/2013 - 01/2005
12Type 2 Diabetes Mellitus (MODY)
12/2013 - 04/2003
11Insulin Resistance
11/2013 - 10/2003
9Cardiovascular Diseases (Cardiovascular Disease)
12/2021 - 12/2002
9Hypertension (High Blood Pressure)
01/2021 - 10/2003
7Coronary Artery Disease (Coronary Atherosclerosis)
01/2015 - 03/2002
6Dyslipidemias (Dyslipidemia)
04/2009 - 01/2005
5Myocardial Infarction
03/2014 - 11/2004
5Inflammation (Inflammations)
03/2014 - 03/2002
5Coronary Disease (Coronary Heart Disease)
05/2013 - 02/2003
4Overweight
01/2019 - 06/2007
3Acute Coronary Syndrome
12/2021 - 09/2005
3Neoplasms (Cancer)
01/2021 - 09/2008
3Glucose Intolerance
05/2020 - 06/2012
3Body Weight (Weight, Body)
02/2013 - 02/2009
3Carotid Artery Diseases
06/2012 - 05/2003
3Weight Gain
05/2012 - 11/2005
3Pathologic Constriction (Stenosis)
03/2011 - 05/2003
2Heart Failure
12/2021 - 09/2008
2Non-alcoholic Fatty Liver Disease
01/2017 - 01/2015
2Stroke (Strokes)
05/2013 - 09/2008
2Fatty Liver
10/2012 - 11/2011
2Vascular Diseases (Vascular Disease)
01/2009 - 03/2003
1Chronic Disease (Chronic Diseases)
07/2021
1Fibrosis (Cirrhosis)
07/2021
1Pathologic Processes
01/2021
1Carotid Stenosis (Carotid Artery Stenosis)
10/2013
1Atherosclerotic Plaque (Atheroma)
10/2013
1Uremia
10/2013

Drug/Important Bio-Agent (IBA)

17LipidsIBA
12/2019 - 04/2004
14Simvastatin (Zocor)FDA LinkGeneric
01/2022 - 09/2008
14Ezetimibe (Zetia)FDA Link
01/2022 - 09/2008
10oxidized low density lipoproteinIBA
12/2019 - 10/2003
10AdiponectinIBA
10/2014 - 01/2005
9Glucose (Dextrose)FDA LinkGeneric
05/2020 - 01/2005
9C-Reactive ProteinIBA
01/2019 - 09/2007
9Insulin (Novolin)FDA Link
05/2012 - 10/2003
8ResistinIBA
01/2021 - 07/2006
8HDL CholesterolIBA
10/2012 - 02/2003
8GhrelinIBA
11/2011 - 10/2003
6LDL CholesterolIBA
01/2021 - 10/2005
6AdipokinesIBA
12/2013 - 01/2005
6Triglycerides (Triacylglycerol)IBA
11/2013 - 01/2005
6CholesterolIBA
06/2011 - 01/2005
5Indicators and Reagents (Reagents)IBA
03/2014 - 11/2006
5LeptinIBA
11/2013 - 09/2007
4Biomarkers (Surrogate Marker)IBA
07/2021 - 11/2006
4LDL Lipoproteins (beta Lipoproteins)IBA
12/2019 - 07/2009
4AntibodiesIBA
01/2018 - 10/2008
4Lipoproteins (Lipoprotein)IBA
06/2010 - 10/2003
4Gemfibrozil (Lopid)FDA LinkGeneric
04/2004 - 03/2002
3Hemoglobins (Hemoglobin)IBA
10/2021 - 10/2013
3Immunoglobulin M (IgM)IBA
01/2018 - 10/2003
3Immunoglobulin G (IgG)IBA
01/2018 - 05/2010
3Immunoglobulin A (IgA)IBA
01/2018 - 05/2010
3Interleukin-6 (Interleukin 6)IBA
12/2013 - 07/2005
3AutoantibodiesIBA
10/2013 - 10/2003
3Proteins (Proteins, Gene)FDA Link
10/2013 - 11/2004
3Peptide Hormones (Polypeptide Hormones)IBA
08/2013 - 04/2009
3Apolipoproteins B (ApoB)IBA
01/2013 - 11/2005
3Fenofibrate (CiL)FDA LinkGeneric
01/2010 - 01/2003
2Phosphorylcholine (Phosphocholine)IBA
01/2018 - 05/2010
2Hormones (Hormone)IBA
12/2016 - 07/2006
2Alanine Transaminase (SGPT)IBA
01/2015 - 10/2012
2Leptin ReceptorsIBA
01/2014 - 10/2010
2FructoseIBA
11/2013 - 02/2013
2CytokinesIBA
11/2011 - 10/2008
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2011 - 11/2009
2Ghrelin ReceptorsIBA
11/2009 - 04/2004
2Adenosine Triphosphate (ATP)IBA
04/2008 - 01/2005
2Insulin-Like Growth Factor I (IGF-1)IBA
01/2008 - 04/2004
2TroponinIBA
10/2006 - 09/2005
2Aryldialkylphosphatase (Paraoxonase)IBA
12/2004 - 10/2002
2Platelet Endothelial Cell Adhesion Molecule-1IBA
11/2004 - 05/2003
2HomocysteineIBA
02/2004 - 03/2003
1Brain Natriuretic Peptide (Natrecor)FDA Link
01/2022
1pro-brain natriuretic peptide (1-76)IBA
01/2022
1omega-Chloroacetophenone (Mace)IBA
12/2021
1Urokinase Plasminogen Activator ReceptorsIBA
01/2018
11,3,4,5,6-pentachlorocyclohexene-1-oxideIBA
01/2018
1Phospholipases (Phospholipase)IBA
01/2017
1Antihypertensive Agents (Antihypertensives)IBA
01/2017
1Atrial Natriuretic Factor (ANF)IBA
01/2015
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
07/2014
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
07/2014
1Cell-Free Nucleic AcidsIBA
03/2014
1DNA (Deoxyribonucleic Acid)IBA
03/2014
1Malondialdehyde (Propanedial)IBA
12/2013
1glycosylated insulinIBA
12/2013
1AcetaldehydeIBA
12/2013
1SmokeIBA
10/2013
1Heme (Haem)IBA
10/2013
1HaptoglobinsIBA
10/2013
1IronIBA
10/2013
1Phosphates (Orthophosphate)IBA
10/2013
1LDL Receptors (LDL Receptor)IBA
10/2013

Therapy/Procedure

9Therapeutics
12/2019 - 11/2005